RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Qsam Biosciences Stock

Qsam Biosciences Stocks 2024

Qsam Biosciences Stocks

1.76 M

Ticker

QSAM

ISIN

US74738N1037

WKN

A2QERD

In 2024, Qsam Biosciences had 1.76 M outstanding stocks, a 122.61% change from the 791,600 stocks in the previous year.

The Qsam Biosciences Stocks history

YEARNUMBER OF STOCKS (undefined USD)
20221.76
20210.79
20200.14
20190.05
20180.05
20170.05
20160.03
20150.67

Qsam Biosciences shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Qsam Biosciences earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Qsam Biosciences's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Qsam Biosciences’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Qsam Biosciences's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Qsam Biosciences Aktienanalyse

What does Qsam Biosciences do?

Qsam Biosciences Inc. is a pharmaceutical and biotechnology company specializing in the development and marketing of innovative medicines and diagnostics. The company was founded in 2004 by a group of scientists with the goal of developing innovative and effective therapies for various diseases. The business model of Qsam Biosciences is based on close collaboration between experts in molecular biology, biochemistry, biophysics, and pharmacology. State-of-the-art technologies and methods are used to explore new drugs, characterize their pharmacological effects, and test their efficacy and safety in rigorous clinical trials. A particular focus is on the development of therapies for cancer, autoimmune diseases, and neurodegenerative diseases such as Alzheimer's and Parkinson's. Qsam Biosciences already has promising candidates in its pipeline, which are being tested in phase 2 and phase 3 studies. In addition to developing new drugs, Qsam Biosciences also operates a diagnostics division that focuses on developing new test methods for early detection of diseases. Molecular diagnostic methods are particularly used to detect diseases such as cancer, cardiovascular diseases, and infectious diseases at an early stage. Among Qsam Biosciences' key products are a range of antibodies and protein inhibitors that specifically target disease-specific targets, demonstrating high efficacy and precision. These drugs are used both as monotherapy and in combination with other medications to ensure optimal treatment. One particular highlight is the drug QB-101, currently being developed for the treatment of Parkinson's disease. QB-101 is a novel protein inhibitor that specifically inhibits the activity of dopamine-degrading enzymes, reducing dopamine breakdown in the brain. QB-101 has already shown promising results in clinical trials and is currently being tested in a large phase 2 study. Overall, Qsam Biosciences is an innovative and dynamic company that makes a significant contribution to the fight against serious diseases with its products and services. With the use of state-of-the-art technologies and methods, as well as close collaboration between experts from different disciplines, Qsam Biosciences is well positioned to develop effective medicines and diagnostics that can improve and prolong patients' lives. Qsam Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Qsam Biosciences's Shares Outstanding

Qsam Biosciences's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Qsam Biosciences’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Qsam Biosciences’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Qsam Biosciences’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Qsam Biosciences stock

How many stocks are there of Qsam Biosciences?

The current number of stocks of Qsam Biosciences is 1.76 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Qsam Biosciences are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Qsam Biosciences evolved in recent years?

The number of shares of Qsam Biosciences has increased by 122.61% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Qsam Biosciences as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Qsam Biosciences?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Qsam Biosciences pay?

Over the past 12 months, Qsam Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Qsam Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Qsam Biosciences?

The current dividend yield of Qsam Biosciences is .

When does Qsam Biosciences pay dividends?

Qsam Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Qsam Biosciences?

Qsam Biosciences paid dividends every year for the past 0 years.

What is the dividend of Qsam Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Qsam Biosciences located?

Qsam Biosciences is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von Qsam Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Qsam Biosciences from 9/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Qsam Biosciences pay the last dividend?

The last dividend was paid out on 9/27/2024.

What was the dividend of Qsam Biosciences in the year 2023?

In the year 2023, Qsam Biosciences distributed 0 USD as dividends.

In which currency does Qsam Biosciences pay out the dividend?

The dividends of Qsam Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Qsam Biosciences

Our stock analysis for Qsam Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Qsam Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.